Overview
Emil Gustavsson practices in London, United Kingdom. Mr. Gustavsson is highly rated in 5 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Movement Disorders, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Deep Brain Stimulation.
His clinical research consists of co-authoring 52 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Movement DisordersMr. Gustavsson isAdvanced. Learn about Movement Disorders.
- Parkinson's DiseaseMr. Gustavsson isAdvanced. Learn about Parkinson's Disease.
- Primary Lateral SclerosisMr. Gustavsson isAdvanced. Learn about Primary Lateral Sclerosis.
- Spinocerebellar AtaxiaMr. Gustavsson isAdvanced. Learn about Spinocerebellar Ataxia.
- Experienced
- Acute Cerebellar AtaxiaMr. Gustavsson isExperienced. Learn about Acute Cerebellar Ataxia.
- Alzheimer's DiseaseMr. Gustavsson isExperienced. Learn about Alzheimer's Disease.
- Batten DiseaseMr. Gustavsson isExperienced. Learn about Batten Disease.
- Brown SyndromeMr. Gustavsson isExperienced. Learn about Brown Syndrome.
- CLN1 DiseaseMr. Gustavsson isExperienced. Learn about CLN1 Disease.
- CLN2 DiseaseMr. Gustavsson isExperienced. Learn about CLN2 Disease.